Effect of low-density lipoproteins on mesangial cell expression of monocyte chemoattractant peptides

Contributions to Nephrology

Volumn 120, Issue , 1997, Pages 176-190

  Kamanna, Vaijinath S ^b   Kirschenbaum, Michael A ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOTACTIC FACTOR; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; LOW DENSITY LIPOPROTEIN;

ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; HUMAN; KIDNEY DISEASE; MESANGIUM; METABOLISM; NEUTROPHIL CHEMOTAXIS; REVIEW;

ANIMALS; CELLS, CULTURED; CHEMOKINES; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; COLONY-STIMULATING FACTORS; GLOMERULAR MESANGIUM; HUMANS; KIDNEY DISEASES; LIPOPROTEINS, LDL; MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 0030625555     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059836     Document Type: Review

References (65)

1. Schreiner GF: The role of the macrophage in glomerular injury. Semin Nephrol 1991;11:268-275.
2. Magil AB, Cohen AH: Monocytes and focal glomerulosclerosis. Lab Invest 1989;61:404-409.
3. Hooke DH, Hancock WW, Gee DC, Kraft N, Atkins RC: Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis. Clin Nephrol 1984;22:163-168.
4. Nolasco FEB, Cameron JS, Hartley B, Coelho A, Hildreth G, Reuben R: Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 1987;31:1160-1166.
5. Schreiner GF, Rovin B, Lefkowith JB: The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. J Immunol 1989;143:3192-3199.
6. Schreiner GF, Cotran RS, Pardo V, Wnanue ER: A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med 1978;147:369-384.
7. Diamond JR, Pesek I, Ruggienri S, Kamovsky MJ: Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 1989;257:F789-F807.
8. Saito T, Atkins RC: Contribution of mononuclear leukocytes to the progression of experimental focal glomerulosclerosis. Kidney Int 1990;37:1076-1083.
9. Van Goor H, Marian LC, Horst VD, Fidler V, Grond J: Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest 1982;66:564-571.
10. Diamond JR, Pesck I, McCarter MD, Karnvosky MJ: Alterations in rat macrophage function during nephrosis: Synergistic effects of hypercholesterolemia. Am J Pathol 1989;135:711-718.
11. Kasiske BL, O'Donnell MP, Schmitz PG; Kim Y, Keane WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 1990;37:880-891.
12. Kamanna VS, Kirschenbaum MA: Association between very low density lipoprotein and glomerular injury in Zucker obese rats. Am J Nephrol 1993;13:53-58.
13. El Nahas AM: Growth factors and glomerular sclerosis. Kidney Int 1992;36:S-15-S-20.
14. Rice GE, Munro JM, Corless C, Bevilacque MP: Vascular and nonvascular expression of INCAM-110: A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 1991;138:385-393.
15. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osbom L, Lobb R, Harlan J: Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 1991;77:2266-2271.
16. Brady HR, Denton MD, Jimenez W, Takala S, Palliser D, Brenner BM: Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 1992;42:480-487.
17. Brady HR: Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994;45:1285-1300.
18. Briscoe DM, Cotran RS: Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: In vitro and in vivo studies. Kidney Int 1993;44(suppl 42):S27-S34.
19. Jadus MR. Pai R. Horansky E, Wepsic HT, Kirschenbaum MA, Kamanna VS: Hematopoietic colony stimulatory factor production by a murine mesangial cell line: Gene expression and biological activity. Biochim Biophys Acta 1994;1224:181-188.
20. Baccarini M, Stanley ER: Colony stimulating factor-1; in Habenicht A: Growth Factors, Differentiation Factors and Cytokines. Berlin, Springer, 1990, pp 188-199.
21. Wang JM, Griffin JD, Rambaldi A, Chen ZG, Mantovani A: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 1988;141:575-579.
22. Miller MD, Krangel MS: Biology and chemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
23. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene intercrine cytokine family. Annu Rev Immunol 1991;9:617-648.
24. Rollins BJ, Stier P, Ernst T, Wong GG: The human homologue of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 1989;9:4687-4695.
25. Pai R, Ha H, Kirschenbaum MA, Kamanna VS: Role of TNF-α on mesangial cell MCP-1 expression and monocyte migration: Mechanisms mediated by signal transduction. J Am Soc Nephrol, in press.
26. Yoshimura T, Leonard EJ: Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 1990;145:292-297.
27. Berliner JA, Territo MC, Almada L, Carter A, Shafonsky E, Fogelman AM: Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis 1986;6:254-258.
28. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266.
29. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/mcp-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 1993;92:1564-1571.
30. Pai R, Kirschenbaum MA, Kamanna VS: Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in murine glomerular mesangial cells. Kidney Int 1995;48:1254-1262.
31. Gerrity RG, Naito HK, Richardson M, Schwartz CJ: Dietary-induced atherogenesis in swine: Morphology of the intima in prelesion stages. Am J Pathol 1995;95:775-786.
32. Faggiotto A, Ross R, Harker L: Sudies of hypercholesterolemia in the nonhuman primate. I: Changes that lead to fatty streak formation. Arteriosclerosis 1984;4:323-340.
33. Cushing SD, Berliner JA, Valente JA, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138.
34. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidative modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-2998.
35. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Banshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;35:1260-1266.
36. Li H, Cybulsky MI, Gimbrone MA Jr. Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion modecule in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204.
37. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791.
38. Avram MM: Similarities between glomerulosclerosis and atherosclerosis in human renal biopsy specimens: A role for lipoprotein glomerulopathy. Am J Med 1989;87:39N-41N.
39. Moorhead JF: Lipids and progressive kidney disease. Kidney Int 1991;39:S35-S40.
40. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 1991;39:S34-S48.
41. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991;39:S29-S34.
42. Kamanna VS, Roh DD, Kirschenbaum MA: Atherogenic lipoproteins: Mediators of glomerular injury. Am J Nephrol 1993;13:1-5.
43. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ: Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature 1990;344:254-257.
44. Lehr HA, Krober M, Hubner C, Vajkoczy P, Menger MD, Nolte D, Kohlschutter A, Messmer K: Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice: Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 1993;68:388-395.
45. Lehr HA, Hubner C, Finckh B, Angermuller S, Nolte D, Beisiegel U. Kohlschutter A, Messmer K: Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 1991;88:9-14.
46. Henriksen T, Mahoney EM, Steinberg D: Enhanced macrophage degradation of biologically modified low density lipoprotein. Atherosclerosis 1983;3:149-159.
47. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 1993;43:218-225.
48. Keane WF, Kasiske BL, O'Donnell MP, Schmitz PG: Therapeutic implications of lipid-lowering agents in the progression of renal disease. Am J Med 1989;87:21N-24N.
49. Guijarro C, Keane WF: Lipid-induced glomerular injury. Nephron 1994;67:1-6.
50. Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y: Human mesangial cell production of monocyte chemoattract protein-1: Modulation by lovastatin. Kidney Int 1995;48:363-371.
51. Ha H, Pai R, Kamanna VS, Kirschenbaum MA: Oxidatively modified (ox)-LDL stimulates monocyte (MØ) adhesion to glomerular endothelial cells (EC) mediated by ICAM-1. J Am Soc Nephrol 1995;6:830A.
52. Rovin H, Rumancik M. Tan L, Dickerson J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:530-542.
53. Prodjosudjadi W, Gerritsma JSJ, Mohamad NK, Gerritsen AF, Bruijn JA, Daha MR, Van Es LA: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995;48:1477-1486.
54. Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992;41:191-198.
55. Bloom RD, Florquin S, Singer GG, Brennan DC, Kelley VR: Colony stimulating factor-1 in the induction of lupus nephrities. Kidney Int 1993;43:1000-1009.
56. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-β in experimental hydronephrosis Am J Physiol 1994;266:F926-F933.
57. Stahl RAK, Thaiss F, Disser M, Helmehen U, Hura K, Schlondorff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993;44:1030-1047.
58. Eddy AA: Experimental insights into the tubulointerstitital disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5:1273-1287.
59. Wenzel UO, Abboud HE: Chemokines and renal disease. Am J Kidney Dis 1995;26:982-994.
60. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammatory and fibrosis in rat with protein-overload proteinuria proteinuria. Kidney Int 1995;47:1546-1557.
61. Tam FWK, Karkar AM, Smith J, Yoshimura T, Stemkasserer A, Kurrle R, Langner K, Rees AJ: Differential expression of macrophage inflammatory protein-2 and monocyte chemoattract protein-1 in experimental glomerulonephritis. Kidney Int 1996;49:715-721.
62. Tang WW, Yin S, Wittwer AJ, Qi M: Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol 1995;269:F323-F330.
63. Mai M, Fierlbeck W, Geiger H: Differential expression of MCP-1 and RANTES in experimental renovascular hypertension. J Am Soc Nephrol 1994;5:757A.
64. Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Taubman MB: Expression of cytokine-like genes JE and KC increased during renal ischemia. Am J Physiol 1991;261:F1095-F1101.
65. Gomez-Chiarri M, Ortiz A, Seron D, Gonzalez E, Egido J: The intercine superfamily and renal disease. Kidney Int 1993;43(suppl 39):S81-S85.